Aastrom Biosciences Receives Patent Expanding Coverage for its Single-pass Perfusion Technology

Patent Extends Coverage from Stem Cell Population to Dendritic Cells

17-Jan-2005 - Aastrom Biosciences, Inc. announced that it has received a patent providing expanded coverage for the Company's single-pass perfusion technology to cover enhancing the biological functionality of human dendritic cells produced in cell culture. Dendritic cells are in clinical trials and ...

Frost & Sullivan: Medical Technologies Europe 2005 Executive Summit

13-Jan-2005 - Frost & Sullivan is proud to announce its first European Medical Technologies 2005 Executive Summit, which will be held on 14th - 16th February 2005 at the Novotel Hotel, London, United Kingdom. Medical technology companies of all sizes will gather to assess the state of the European medical ...

Genmap's HuMax-CD20 to Treat CLL Awarded Fast Track Status From FDA

17-Dec-2004 - Genmab A/S announced that HuMax(TM)-CD20 has been designated a Fast Track Product by the US Food and Drug Administration (FDA). This designation covers patients with chronic lymphocytic leukemia (CLL) who have failed fludarabine therapy. This patient group includes those who are refractory to ...

Study: Desires for fatty foods and alcohol share a chemical trigger

17-Dec-2004 - A brain chemical that stokes hunger for food and fat also triggers thirst for alcohol and may play a role in chronic drinking, according to a study led by Princeton University scientists. The study showed that rats injected with galanin, a natural signaling agent in the brain, chose to drink ...

SEQUENOM Reports An Important Discovery of Gene Involved in Breast and Prostate Cancer

17-Dec-2004 - The recent discovery of common genetic variations in intercellular adhesion molecule (ICAM) genes was announced by SEQUENOM, Inc. and is believed to be among the most important findings in cancer genetics since the discovery of BRCA1 and BRCA2. Published in the December 15, 2004 issue of Cancer ...

The Human Side of Science: What is the Archetypal Researcher Personality?

16-Dec-2004 - Arlington. Are there some personalities that are better suited than others to a scientific career? To provide insight into this issue, The Science Advisory Board created the first-ever psychological profile of life science researchers, the Scientific Personality Assessment (SPA). The SPA is meant ...

French ExonHit Therapeutics Achieves First Research Milestone in its Collaboration with Allergan

Compound Synthesized at ExonHit Demonstrates Promising Preclinical Profile

14-Dec-2004 - ExonHit Therapeutics announced that it has reached a first research milestone in its collaboration with Allergan. A new orally active small molecule was synthesized by ExonHit's chemists to modulate a pathway identified by ExonHit's alternative splicing profiling technology, DATAS®, in tissues ...

Study: Target Specificity is Primary Focus of Research in RNAi Technologies

13-Dec-2004 - While ribonucleic acid interference (RNAi) offers a fresh approach to drug discovery, validation, and delivery, current research efforts gears toward improving target specificity. In this regard, scientists are giving top priority to finding the most efficient means to deliver or transfect ...

Proteo Biotech AG Signs an Exclusive License- and Collaboration-Agreement with Artes Biotechnology GmbH

Leading Technology for the Recombinant Production of Elafin Worldwide Secured

10-Dec-2004 - Proteo Biotech is producing its Elafin with the patent protected yeast strain Hansenula polymorpha on a recombinant basis for a world market. PROTEO has signed an exclusive License- and collaboration agreement with ARTES Biotechnology GmbH. ,,This agreement will enable us to produce Elafin, in a ...

Stem cell research: The new medicine of the future

09-Dec-2004 - United Kingdom and California lead the way to find cures through stem cell research While the federal government ponders the ethical implications of therapeutic cloning, California is blazing a trail to the future. The Golden State has caught the attention of stem-cell scientists across the world ...